biology3 papersavg year 2025weak evidence

Technical and regulatory challenges persist

Research gap analysis derived from 3 biology papers in our local library.

The gap

Technical and regulatory challenges persist in translating exosome-based therapeutics from bench to clinic.

Evidence profile

Sourced from the future work and open questions of the source papers, classified as application gap, drawn from work published between 2023 and 2026, spanning 3 journals. Those papers have been cited 7 times in total.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 3 representative gaps

  • Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases (2025) · Cells · cited 7× · doi

    Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes-based therapeutics need to be more fully developed and standardized.

    application gapfuture workevidence 4/5
    Keywords: guidelines clinical translation commercialization extracellular vesicles exosomes based therapeutics need fully developed standardized
  • Extracellular vesicles – biogenesis and role in cancer treatment (2023) · Reviews in Biological and Biomedical Sciences · doi

    Using exosomes as diagnostic tools in cancer has an optimistic future, but clinical application as drug delivery systems requires further development since research in this domain is vastly developing.

    application gapfuture workevidence 4/5
    Keywords: using exosomes diagnostic tools cancer optimistic future clinical application drug delivery systems requires further development
  • Exosomes as Targeted Drug Delivery Systems: Strategies and Mechanisms for Mitigating Cisplatin-Induced Hair Cell Damage (2026) · International Journal of Biology and Life Sciences · doi

    Technical and regulatory challenges persist in translating exosome-based therapeutics from bench to clinic.

    application gapopen questionsevidence 3/5
    Keywords: technical regulatory challenges persist translating exosome based therapeutics bench clinic

Questions about this gap

Technical and regulatory challenges persist in translating exosome-based therapeutics from bench to clinic. This is supported by 3 representative gap statements extracted from 3 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.

Related gaps in Biology

Command palette

Jump anywhere, run any action.